Lead Product(s) : Griseofulvin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Cosette Pharmaceuticals Announces the Launch of Griseofulvin Oral Suspension, 125 mg/5 mL.
Details : Griseofulvin microsize contains griseofulvin microsize for oral administration. The active ingredient, griseofulvin, is a fungistatic antibiotic, derived from a species of Penicillium.
Product Name : Griseofulvin-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 12, 2022
Lead Product(s) : Griseofulvin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
